Home > Healthcare > Medical Devices > Diagnostic Devices > Ovulation Testing Kits Market

Ovulation Testing Kits Market Trends

Report ID: GMI7248
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

Ovulation Testing Kits Market Trends

A range of factors, including lifestyle changes, stress, and delayed childbearing, has led to an increase in fertility issues among women. For instance, according to the CDC data, in the U.S., approximately 11% of women of childbearing age experience infertility, and about 6% of married women aged 15 to 49 years face infertility. Thus, ovulation testing kits provide a cost-effective and non-invasive means of understanding one's fertility window, helping couples address these challenges and plan for pregnancy effectively.

Furthermore, ovulation testing kits have evolved significantly in terms of accuracy and ease of use. Modern kits often utilize advanced technology, such as digital displays and connectivity with smartphone apps, making it more convenient for individuals to monitor their fertility window.
For instance, Clearblue's advanced digital ovulation test offers digital results and smartphone app synchronization, enhancing fertility tracking accuracy and convenience. These advancements contribute to the market's growth by improving user experience and reliability.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global ovulation testing kits indystry was valued at USD 1.8 billion in 2022 and is estimated to reach USD 4.2 billion by 2032.

The pharmacies and drugstores segment accounted for over 41% market share in 2022 and will grow through 2032 as these stores offer easy accessibility, provide professional guidance, and a variety of product options.

U.S. ovulation testing kits market accounted for USD 672 million in 2022 and is predicted to witness substantial growth through 2032 primarily due to the region’s high fertility awareness, robust healthcare infrastructure, consumer affluence, and effective marketing efforts.

Swiss Precision Diagnostics GmbH (Clearblue), ClinicalGuard, Wondfo, AccuMed, PREGMATE, iProven, and Wellify (Piramal group), Femometer, Proov, Easy@Home Fertility, Ro, Fairhaven Health, and Prega News (Mankind pharma).